Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Study identifies critical genes and biological pathways related to COVID-19 myocarditis

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

Evolution of SARS-CoV-2 genomes based on continuing positive selection

Evolution of SARS-CoV-2 genomes based on continuing positive selection

Effectiveness of monoclonal antibodies and directly acting antivirals against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages

Effectiveness of monoclonal antibodies and directly acting antivirals against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages

The potential of DNA-based SARS-CoV-2 vaccine candidates

The potential of DNA-based SARS-CoV-2 vaccine candidates

A data commons to accelerate research in COVID and long-COVID

A data commons to accelerate research in COVID and long-COVID

Cell-based assay highlights differences in antibody neutralizing capacity for SARS-CoV-2 variants

Cell-based assay highlights differences in antibody neutralizing capacity for SARS-CoV-2 variants

A cancer patient who had SARS-CoV-2 for over eight months

A cancer patient who had SARS-CoV-2 for over eight months

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

In 1st year of pandemic, COVID vaccines saved 20M lives

In 1st year of pandemic, COVID vaccines saved 20M lives

Recombinant SARS-CoV-2 harboring double reporters for COVID-19 surveillance

Recombinant SARS-CoV-2 harboring double reporters for COVID-19 surveillance

3rd COVID vaccine significantly reduced hospitalizations and deaths during Australia's 1st Omicron wave

3rd COVID vaccine significantly reduced hospitalizations and deaths during Australia's 1st Omicron wave

Lipid-peptide nanocomplexes offer new mRNA platform

Lipid-peptide nanocomplexes offer new mRNA platform

Scientists conduct meta-analysis of the impact of SARS-CoV-2 on sperm parameters

Scientists conduct meta-analysis of the impact of SARS-CoV-2 on sperm parameters

Researchers investigate clinical epidemiological impact of Omicron among hospitalized COVID-19 patients

Researchers investigate clinical epidemiological impact of Omicron among hospitalized COVID-19 patients

Breakthrough infection with pre-Omicron variant induces cross-neutralizing activity against Omicron

Breakthrough infection with pre-Omicron variant induces cross-neutralizing activity against Omicron

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

A full model of the SARS-CoV-2 spike protein for studying its atomic-level dynamics by multiple microsecond simulations

A full model of the SARS-CoV-2 spike protein for studying its atomic-level dynamics by multiple microsecond simulations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.